about
Gene therapy: progress and predictionsPerformance Enhancement: What Are the Physiological Limits?Physiology and pharmacology of erythropoietinIntolerability of cobalt salt as erythropoietic agent.Speed trends in male distance running.The optimum hematocrit.Recombinant erythropoietin in humans has a prolonged effect on circulating erythropoietin isoform distribution.The evolving science of detection of 'blood doping'.Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate StatisticsRed blood cells in sports: effects of exercise and training on oxygen supply by red blood cellsTotal haemoglobin mass, blood volume and morphological indices among athletes from different sport disciplines.Doping Attitudes and Covariates of Potential Doping Behaviour in High-Level Team-Sport Athletes; Gender Specific Analysis.Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.Dose-response relationships for blood cobalt concentrations and health effects: a review of the literature and application of a biokinetic model.Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.Monitoring of biological markers indicative of doping: the athlete biological passport.Blood doping: potential of blood and urine sampling to detect autologous transfusion.Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.Micronutrients (B, Co, Cu, Fe, Mn, Mo, and Zn) content in made tea (Camellia sinensis L.) and tea infusion with health prospect: A critical review.Investigation and Management of Erythrocytosis.Red cell volume response to exercise training: Association with aging.Biology of VO2 max: looking under the physiology lamp.Protective effects of kolaviron and gallic acid against cobalt-chloride-induced cardiorenal dysfunction via suppression of oxidative stress and activation of the ERK signaling pathway.Gender- and Sport-Specific Associations Between Religiousness and Doping Behavior in High-Level Team Sports.Diagnosis and management of congenital and idiopathic erythrocytosis.Establishment of two quantitative nested qPCR assays targeting the human EPO transgene.Ex vivo erythrocyte generation and blood doping.Altitude exposure in sports: the Athlete Biological Passport standpoint.Optimal hematocrit in an artificial microvascular network.Erythropoiesis with endurance training: dynamics and mechanisms.Haematological rather than skeletal muscle adaptations contribute to the increase in peak oxygen uptake induced by moderate endurance training.Ethical Concerns in Sport: When the Will to Win Exceed the Spirit of SportEvaluation of serum markers for improved detection of autologous blood transfusions
P2860
Q26772109-4EDCD85D-F184-47FF-BEE9-185B5F3D72D7Q26866551-A876003F-0C80-47DD-99C8-590D6822AC8EQ26866945-F80D9E68-BE74-4B8D-BAE6-0E8470AC1DAAQ34038171-49BBC2D2-5CD5-4A62-A697-FC9CF4FDE812Q34542857-FBF7BF2F-FF19-4289-8520-F1DEAF314518Q34679370-AE3CEC02-4A90-44C9-825B-1747DF268B5BQ35356050-D56B4522-CDEC-4885-B8E6-2532F2FD64ADQ36024838-6A32460D-5004-4029-913D-E4A031792843Q36048055-47979636-22B0-4881-81E1-15930A4FD712Q37298190-261027EB-066F-418F-B60D-FBFF2A93EA17Q37321884-4D6FAFF2-92F3-474E-82B6-C0605BEBE2B6Q37459684-A008AA7B-58EB-47E3-9D5E-31BC6394AF9EQ38029405-53288F1B-A29F-4DB0-91D1-39227A08CF5CQ38063953-4E3F446A-F3CD-4661-8AFA-59669683058AQ38127386-B915D925-85D8-46EF-B10B-C8D1FA64AD2FQ38198584-01F53D22-4972-4E70-9317-A5F9A7345EBDQ38207008-5F753C62-E46A-4046-B031-8D066DCBE244Q38589015-CBF2EBA6-EB7C-47FE-90E0-2FE21BA420BFQ38610640-5545AAE2-EF3E-439A-B706-9C2BD8203234Q38898732-17C7A369-1AAB-4418-B45B-502AF62B48BCQ39012327-0DDAA10E-86FD-4066-87EB-CA5444544F42Q39020493-0F416ED5-02E1-44A5-B350-780CC54C3DD3Q39466665-FDCEE67C-B414-40CD-AFBE-9C83C7B5B219Q39775415-4A5F5B20-5F6A-4D0B-8D9D-763C91715FCBQ39869449-D28C6932-3205-402D-AEC8-5C28692525EAQ40986812-8137DD73-3526-402E-B446-D1722CDB247BQ43195888-2BDC8831-0F16-4A8A-987F-21BF78247864Q43840740-41C01368-D3AA-4DDC-ADB4-84B454F4A133Q47954573-B50FF9B7-2429-44EE-AA4D-8BB905D5082EQ50211526-99AC3530-6610-467B-82B5-CA63CFCC7D00Q50438268-BAA4960F-F449-467E-A410-225A6CC1E3E6Q58657075-95B86940-CAE5-4962-BFA4-7E039796CC84Q58793848-E15660DA-CC83-444B-B472-7D1561B96DAB
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Blood doping and its detection
@ast
Blood doping and its detection
@en
Blood doping and its detection
@nl
type
label
Blood doping and its detection
@ast
Blood doping and its detection
@en
Blood doping and its detection
@nl
prefLabel
Blood doping and its detection
@ast
Blood doping and its detection
@en
Blood doping and its detection
@nl
P3181
P1433
P1476
Blood doping and its detection
@en
P2093
Carsten Lundby
Wolfgang Jelkmann
P304
P3181
P356
10.1182/BLOOD-2011-02-303271
P407
P577
2011-09-01T00:00:00Z